Raymond has over 15 years of experience in cancer research. After obtaining his PhD from the University of Zurich (Switzerland) in 2006, he joined the Dana Farber Cancer Institute (Harvard Medical School) in Boston (USA) as a postdoctoral research fellow. In 2009 he returned to the Netherlands and joined the Hubrecht Institute in Utrecht (Netherlands). Raymond authored 7 papers in renowned international peer reviewed journals.
Raymond started at SMS-oncology as a Consultant oncology drug development in January 2010 and led the consultancy group from October 2012 to February 2015 as Director Consultancy. In these positions, he supported many clients by giving proficient advice and translating science into realistic and pragmatic clinical study designs.
As of January 2014, Raymond is Chief Business Development Officer and is instrumental in the continuous success and growth of SMS-oncology since then. In July 2019, Raymond also became the Managing Director of the German subsidiary company SMS-oncology GmbH.